1262412-30-5 Usage
General Description
5-Bromo-3-fluoro-2-(trifluoromethyl)pyridine is a chemical compound with the molecular formula C6H2BrF4N. It is a pyridine derivative with three fluorine atoms and one bromine atom attached to the pyridine ring. 5-Bromo-3-fluoro-2-(trifluoromethyl)pyridine is used as a building block in organic synthesis and medicinal chemistry. It is known for its strong fluorine and bromine substituents, which make it useful in the development of pharmaceuticals and agrochemicals. Additionally, its trifluoromethyl group enhances the compound's lipophilicity, which can improve its bioavailability and distribution in the body. The compound is also used in the preparation of specialty chemicals and materials, due to its unique chemical properties and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 1262412-30-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,4,1 and 2 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1262412-30:
(9*1)+(8*2)+(7*6)+(6*2)+(5*4)+(4*1)+(3*2)+(2*3)+(1*0)=115
115 % 10 = 5
So 1262412-30-5 is a valid CAS Registry Number.
1262412-30-5Relevant articles and documents
AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS
-
Page/Page column 301, (2021/04/02)
Provided herein are compounds of Formula (I) and Formula (II): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of tuberculosis.
SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
-
Paragraph 0910; 0911, (2015/04/28)
The invention is concerned with the compounds of formula I or II: and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I or II as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
